Universal Ibogaine Inc

TSXV:IBO (Canada)  
C$ 0.02 (0%) Sep 25
At Loss
P/B:
3.00
Market Cap:
C$ 4.63M ($ 3.44M)
Enterprise V:
C$ 6.93M ($ 5.14M)
Volume:
-
Avg Vol (2M):
43.70K
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Universal Ibogaine Inc ( TSXV:IBO ) from 2017 to Sep 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Universal Ibogaine stock (TSXV:IBO) PE ratio as of Sep 26 2024 is 0. More Details

Universal Ibogaine Inc (TSXV:IBO) PE Ratio (TTM) Chart

To

Universal Ibogaine Inc (TSXV:IBO) PE Ratio (TTM) Historical Data

Total 1283
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Universal Ibogaine PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-26 At Loss 2024-07-24 At Loss
2024-09-25 At Loss 2024-07-23 At Loss
2024-09-24 At Loss 2024-07-22 At Loss
2024-09-23 At Loss 2024-07-19 At Loss
2024-09-20 At Loss 2024-07-18 At Loss
2024-09-19 At Loss 2024-07-17 At Loss
2024-09-18 At Loss 2024-07-16 At Loss
2024-09-17 At Loss 2024-07-15 At Loss
2024-09-16 At Loss 2024-07-12 At Loss
2024-09-13 At Loss 2024-07-11 At Loss
2024-09-12 At Loss 2024-07-10 At Loss
2024-09-11 At Loss 2024-07-09 At Loss
2024-09-10 At Loss 2024-07-08 At Loss
2024-09-09 At Loss 2024-07-05 At Loss
2024-09-06 At Loss 2024-07-04 At Loss
2024-09-05 At Loss 2024-07-03 At Loss
2024-09-04 At Loss 2024-07-02 At Loss
2024-09-03 At Loss 2024-07-01 At Loss
2024-08-30 At Loss 2024-06-28 At Loss
2024-08-29 At Loss 2024-06-27 At Loss
2024-08-28 At Loss 2024-06-26 At Loss
2024-08-27 At Loss 2024-06-25 At Loss
2024-08-26 At Loss 2024-06-24 At Loss
2024-08-23 At Loss 2024-06-21 At Loss
2024-08-22 At Loss 2024-06-20 At Loss
2024-08-21 At Loss 2024-06-19 At Loss
2024-08-20 At Loss 2024-06-18 At Loss
2024-08-19 At Loss 2024-06-17 At Loss
2024-08-16 At Loss 2024-06-14 At Loss
2024-08-15 At Loss 2024-06-13 At Loss
2024-08-14 At Loss 2024-06-12 At Loss
2024-08-13 At Loss 2024-06-11 At Loss
2024-08-12 At Loss 2024-06-10 At Loss
2024-08-09 At Loss 2024-06-07 At Loss
2024-08-08 At Loss 2024-06-06 At Loss
2024-08-07 At Loss 2024-06-05 At Loss
2024-08-06 At Loss 2024-06-04 At Loss
2024-08-05 At Loss 2024-06-03 At Loss
2024-08-02 At Loss 2024-05-31 At Loss
2024-08-01 At Loss 2024-05-30 At Loss
2024-07-31 At Loss 2024-05-29 At Loss
2024-07-30 At Loss 2024-05-28 At Loss
2024-07-29 At Loss 2024-05-27 At Loss
2024-07-26 At Loss 2024-05-24 At Loss
2024-07-25 At Loss 2024-05-23 At Loss

Universal Ibogaine Inc (TSXV:IBO) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.